[Details]
Editor’s Note: At The Daily FWD we’re always looking out for special opportunities we believe you, as a valued subscriber, will want to see. Below you’ll find one from our partners at Logical Health Alternatives. Please note that their opinions may differ from ours. Kills more cancer cells than a dose of radiation In 1918, this "miracle medicine" was in every household in America. Valuable enough to get caught in the crossfire during both World Wars... And powerful enough to be studied by the founding members of a massive Big Pharma dynasty... There was nothing else like it on Earth. In fact, this miracle medicine was on track to become a game-changer for fighting the cancer epidemic. But then it just...disappeared. To this day, it's not being taught in medical schools--or prescribed in major U.S. cancer centers. But the results of lab studies are impressive. Big Pharma knows more about this than they're letting on...and these newly discovered documents prove it... Everything you need to know is right here. To your health, Karen Reddel
Logical Health Alternatives P.S. No one's talking about this--but this discovery is already changing the lives of cancer patients. See it here before corporate interests make it "disappear" again. | |
| | | | © 2024 Paradigm Press, LLC. 1001 Cathedral Street, Baltimore, MD 21201. By submitting your email address, you consent to Paradigm Press, LLC. delivering daily email issues and advertisements. To end your The Daily FWD e-mail subscription and associated external offers sent from The Daily FWD, feel free to click here. Please note: the mailbox associated with this email address is not monitored, so do not reply to this message. We welcome comments or suggestions at feedback@paradigmpressgroup.com. This address is for feedback only. For questions about your account or to speak with customer service, contact us here or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. The Daily FWD is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our Privacy Statement. If you are having trouble receiving your The Daily FWD subscription, you can ensure its arrival in your mailbox by whitelisting The Daily FWD. | | |
No comments:
Post a Comment
Keep a civil tongue.